Compare RNXT & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RNXT | PETS |
|---|---|---|
| Founded | 2012 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail-Drug Stores and Proprietary Stores |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.4M | 61.6M |
| IPO Year | 2021 | 2003 |
| Metric | RNXT | PETS |
|---|---|---|
| Price | $0.83 | $2.66 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 2 | 1 |
| Target Price | ★ $8.00 | $3.20 |
| AVG Volume (30 Days) | ★ 158.7K | 141.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 59.60 | 18.92 |
| EPS | ★ N/A | N/A |
| Revenue | $43,000.00 | ★ $273,800,000.00 |
| Revenue This Year | $2,995.35 | N/A |
| Revenue Next Year | $219.61 | $2.98 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.70 | $1.57 |
| 52 Week High | $1.45 | $4.32 |
| Indicator | RNXT | PETS |
|---|---|---|
| Relative Strength Index (RSI) | 37.19 | 34.73 |
| Support Level | $0.82 | $2.61 |
| Resistance Level | $1.07 | $2.93 |
| Average True Range (ATR) | 0.06 | 0.15 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 9.48 | 10.42 |
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.